What analytical methods are used in bioanalytical services?

 Modern therapeutics range from small molecule synthetic compounds to massive monoclonal antibodies, viral vectors, and living cellular therapies. Because no single technique can analyze every drug type, specialized laboratories maintain diverse technological platforms. Deploying the right bioanalytical services means matching the specific therapeutic modality with the most sensitive and reliable analytical methodology available.

Ligand Binding Assays and Immunoassays

Ligand binding assays, including ELISA and electrochemiluminescence platforms, serve as the gold standard for quantifying large molecules, peptides, and anti-drug antibodies. These methods rely on specific antibody-antigen interactions to achieve high sensitivity in complex biological matrices.

• Enzyme-linked immunosorbent assay for circulating protein quantification

• Electrochemiluminescence assays for expanded dynamic range and lower limits

• Competitive binding formats for measuring free versus bound drug fractions

• Cell-based neutralizing antibody assays to assess functional inhibition

Liquid Chromatography-Mass Spectrometry

Liquid chromatography coupled with tandem mass spectrometry is the premier technology for small molecule quantification, peptide mapping, and metabolic stability assessments. Mass spectrometry separates analytes based on mass-to-charge ratios, delivering exceptional specificity and eliminating cross-reactivity concerns.

• Ultra-high-performance liquid chromatography for rapid chromatographic separation

• Tandem mass spectrometry for precise multiple reaction monitoring

• High-resolution mass spectrometry for untargeted metabolomics and structural elucidation

• Gas chromatography-mass spectrometry for volatile compounds and residual solvents

Molecular Quantification and PCR Technologies

Gene therapies and molecular medicines require specialized nucleic acid quantification techniques. Quantitative PCR and droplet digital PCR platforms measure viral genome titers, vector persistence, and shedding kinetics with absolute precision and exceptional reproducibility.

• Quantitative PCR assays for relative gene expression and biodistribution

• Droplet digital PCR for absolute DNA and RNA copy number quantification

• Reverse transcription PCR for analyzing messenger RNA expression levels

• Sequencing platforms for confirming genetic insert integrity and purity

Flow Cytometry and Cell-Based Assays

Evaluating cellular therapies and immune system dynamics demands advanced flow cytometry and functional cell-based testing. These techniques interrogate individual cells within heterogeneous populations, measuring surface marker expression, intracellular cytokines, and cellular viability.

• Multi-color flow cytometry panels for deep immune phenotyping

• ELISpot assays for quantifying antigen-specific T-cell responses

• Cell proliferation and cytotoxicity assays for potency testing

• Automated cell counting and viability checks for PBMC processing

Conclusion

The analytical toolkit supporting contemporary drug development is remarkably sophisticated. By combining ligand binding assays, mass spectrometry, molecular PCR, and flow cytometry, laboratories extract actionable insights across all therapeutic classes. Choosing a partner with mastery over these diverse platforms ensures comprehensive scientific coverage for every clinical milestone.